SEBI Bars Seven Entities for Social MediaDriven Stock Manipulation Freezes 20 Crore Gains ProfitTaking Strategy Portfolio Manager Trims Stock After 80 Surge Since April Goldman Sachs CEO David Solomon Says AI Unemployment Fears Overblown Sees Potential Job Growth US Government Quantum Stakes Spark Speculation IonQ Micron Anduril on Traders Radar SpaceX Successfully Launches Starship on Second Attempt Advancing Reusable Rocket Development Warren Buffetts Tiny Purchase Remark in March Potentially Uncovered by Latest Berkshire Filing GREEL Q1 2025 Earnings NarrowerThanExpected Loss Highlights Operational Progress Colony Bankcorp Inc CBAN Q1 2026 Earnings Earnings Miss Estimates as EPS Falls Short BJ Q1 2026 Earnings EPS Beat Fails to Lift Stock MasTec MTZ Q1 2026 Earnings Strong EPS Beat Drives Optimism Despite Stock Dip Lakeland Industries LAKE Q1 2026 Earnings Deep EPS Miss Masks Potential Recovery as Stock Rallies BCSF Q1 2026 Earnings Slight EPS Miss Amid Stable Portfolio Performance LaFayette Acquisition Corp Unit LAFAU Holds Steady at 1006 Stability in a SPAC Market Flag Ship Acquisition Corp Rights FSHPR Surge Over 46 Technical and Volume Analysis PeapackGladstone Financial PGC Holds Steady Near 44 as Support Levels Remain in Focus enCore Energy Shares Rise on Renewed Uranium Market Optimism EU Electromed Inc ELMD Gains 226 as Shares Approach Key Resistance Level Quiz Set to Shut All Stores After 33 Years Amid Intensifying Retail Challenges FIGS Q1 2026 Earnings EPS Smashes Estimates by 96 Stock Moves Higher Newbridge Acquisition Unit NBRGU Edges Higher Support and Resistance Levels in Focus Franklin Universal Trust FT Edges Higher Approaching Key Resistance Zone Sidus Space SIDU Tumbles 146 as Selling Pressure Intensifies National Healthcare Properties Preferred Stock NHPAP Hovers Near Resistance After Modest Decline VisionWave VWAVW Extends Bull Run with Another 190 Climb 20260527 RB Global Inc RBA Climbs Nearly 2 as Buyers Defend Key Support Level Duke Energy Preferred Stock DUKB Holds Steady Near Support Amid Modest Gains Foghorn Therapeutics FHTX Rises 144 as Biotech Stock Tests Key Resistance at 443